A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization

• Status: Completed
• Trial end date: 2009-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to test if intravenous sulopenem and an oral drug, PF-03709270 are safe and effective in patients that are hospitalized with community acquired pneumonia.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Lactams

Criteria

Inclusion Criteria:

• Hospitalized male or female patients 18 years of age or older.

• Female patients of childbearing potential must not be pregnant.

• Must exhibit at least two pre-specified clinical symptoms/signs of pneumonia.

• Must require hospitalization for the pneumonia.

• Chest Xray must be suggestive of a pneumonia.

Exclusion Criteria:

• Hospital or ventilator associated pneumonia.

• Patients with cystic fibrosis, pneumocystis carinii pneumonia or active tuberculosis.

• Previous treatment for the current pneumonia episode received for more than 24 hours.

• Allergies to penems or beta lactams.